IRIS UniCatt

Macchia, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.612
EU - Europa 8.173
AS - Asia 7.593
SA - Sud America 1.355
Continente sconosciuto - Info sul continente non disponibili 814
AF - Africa 238
OC - Oceania 15
Totale 29.800
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.242
SG - Singapore 3.487
DE - Germania 2.962
CN - Cina 1.707
SE - Svezia 1.366
BR - Brasile 1.088
IT - Italia 899
VN - Vietnam 728
FR - Francia 655
UA - Ucraina 568
GB - Regno Unito 383
IN - India 370
IE - Irlanda 327
FI - Finlandia 271
ID - Indonesia 221
CA - Canada 206
JP - Giappone 199
PL - Polonia 193
HK - Hong Kong 155
BD - Bangladesh 150
TR - Turchia 139
RU - Federazione Russa 129
AR - Argentina 85
NL - Olanda 82
IQ - Iraq 75
MX - Messico 73
BE - Belgio 56
CI - Costa d'Avorio 54
ZA - Sudafrica 51
CO - Colombia 46
CZ - Repubblica Ceca 44
AT - Austria 43
ES - Italia 43
EC - Ecuador 42
SA - Arabia Saudita 41
IR - Iran 33
KR - Corea 30
PK - Pakistan 30
VE - Venezuela 30
LT - Lituania 29
EG - Egitto 27
MA - Marocco 27
PH - Filippine 27
KE - Kenya 26
JM - Giamaica 25
UZ - Uzbekistan 23
AE - Emirati Arabi Uniti 22
CL - Cile 20
JO - Giordania 19
MY - Malesia 18
NP - Nepal 15
TN - Tunisia 15
PY - Paraguay 14
CH - Svizzera 13
RO - Romania 13
CR - Costa Rica 12
IL - Israele 12
UY - Uruguay 12
EU - Europa 11
AL - Albania 10
AU - Australia 10
AZ - Azerbaigian 9
BH - Bahrain 9
DZ - Algeria 9
GR - Grecia 9
HU - Ungheria 9
PE - Perù 9
RS - Serbia 9
BG - Bulgaria 8
KG - Kirghizistan 8
OM - Oman 8
PT - Portogallo 8
SN - Senegal 8
TT - Trinidad e Tobago 8
BO - Bolivia 7
DK - Danimarca 7
DO - Repubblica Dominicana 7
PS - Palestinian Territory 7
AM - Armenia 6
ET - Etiopia 6
LK - Sri Lanka 6
MT - Malta 6
NI - Nicaragua 6
SY - Repubblica araba siriana 6
HN - Honduras 5
KZ - Kazakistan 5
LB - Libano 5
LU - Lussemburgo 5
NZ - Nuova Zelanda 5
PA - Panama 5
GT - Guatemala 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
BB - Barbados 3
BS - Bahamas 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MK - Macedonia 3
Totale 28.942
Salva come PNG Salva come JPEG
Città #
Singapore 1.919
Chandler 1.365
Ashburn 1.072
San Jose 1.043
Beijing 379
Dublin 323
Jacksonville 322
Los Angeles 290
The Dalles 266
San Mateo 260
New York 250
Ho Chi Minh City 246
Lauterbourg 216
Nanjing 201
Jakarta 194
Milan 192
Wilmington 184
Hanoi 179
Warsaw 169
Dearborn 165
Tokyo 163
Munich 159
Boston 143
Nürnberg 140
Rome 138
Hefei 132
Hong Kong 132
Frankfurt am Main 131
Dallas 130
Bremen 123
Woodbridge 116
Marseille 112
Helsinki 109
Hyderabad 107
Ann Arbor 106
São Paulo 106
Houston 94
Izmir 88
Lawrence 86
Cattolica 84
Princeton 79
Santa Clara 79
Moscow 78
Fairfield 76
Nanchang 76
St Louis 66
Seattle 65
Atlanta 61
Buffalo 60
Chicago 59
Council Bluffs 58
Redwood City 57
Brussels 55
Abidjan 54
Orem 53
Toronto 53
Shanghai 45
London 44
Boardman 43
Brooklyn 40
Leawood 40
Phoenix 38
Montreal 37
Zhengzhou 37
Augusta 36
Düsseldorf 36
Guangzhou 36
University Park 36
Da Nang 35
Stockholm 35
Turku 35
Kent 34
Paris 34
Shenyang 34
Amsterdam 32
Hebei 32
Kunming 32
Phoenixville 32
Tianjin 31
Changsha 29
Fremont 29
Johannesburg 29
Lancaster 29
Nuremberg 29
Lappeenranta 28
Pune 27
Rio de Janeiro 27
Cambridge 26
Detroit 26
Jiaxing 26
Seoul 26
Denver 25
Falls Church 25
Mountain View 25
Mumbai 25
Baghdad 24
Haiphong 24
Mexico City 24
Nairobi 24
San Francisco 24
Totale 14.048
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 868
Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept 309
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 303
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional study 290
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 235
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 234
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 232
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 224
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 224
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 221
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 213
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 207
Development of an Enomogram to Predict the Rate of Loco-Regional Control After Radio-Chemotherapy and Interventional Radiotherapy in Cervical Cancer 203
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 203
Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial 202
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 199
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups 199
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 199
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 198
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 198
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 197
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 196
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 195
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 194
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 193
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 192
In Vivo Portal Dosimetry by an Ionization Chamber 192
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 192
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 189
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 189
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 188
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 187
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 186
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 179
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 179
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 178
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 178
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 177
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 177
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 177
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 177
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 176
Advanced head and neck cancer in older adults: Results of a short course accelerated radiotherapy trial 175
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 174
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 174
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 174
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 173
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 170
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 170
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 169
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 169
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 169
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 168
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 167
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 166
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 165
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 164
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 164
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 163
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 161
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 161
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 161
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 160
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 160
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 159
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 159
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 158
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 158
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 158
Adequacy of Pain Management in Patients Referred for Radiation Therapy: A Subanalysis of the Multicenter ARISE-1 Study 157
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 157
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 155
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 154
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 154
Real time transit dosimetry for the breath-hold radiotherapy technique experience 153
Further Clarification of Pain Management Complexity in Radiotherapy: Insights from Modern Statistical Approaches 152
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 152
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 150
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 148
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 147
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 147
CT angiography-based radiomics as a tool for carotid plaque characterization: a pilot study 146
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 143
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 143
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 142
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 142
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 142
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 142
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 142
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 142
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 141
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 141
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 141
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy 141
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 138
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 138
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 138
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 137
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 137
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer 136
Totale 18.216
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.513
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.320 0 0 15 107 111 57 23 216 62 111 308 310
2022/20233.828 521 539 262 610 263 423 223 292 419 79 148 49
2023/20241.701 66 484 75 129 52 215 101 131 20 52 237 139
2024/20253.772 106 84 240 136 419 103 97 175 600 446 729 637
2025/202610.097 1.417 296 552 962 1.702 580 1.715 619 766 775 387 326
2026/20272.200 507 1.380 313 0 0 0 0 0 0 0 0 0
Totale 29.800